Marimed Stock Performance
| MRMD Stock | USD 0.09 0.0009 1.03% |
The company secures a Beta (Market Risk) of -0.16, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Marimed are expected to decrease at a much lower rate. During the bear market, Marimed is likely to outperform the market. At this point, Marimed has a negative expected return of -0.18%. Please make sure to verify Marimed's skewness, as well as the relationship between the rate of daily change and price action indicator , to decide if Marimed performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Marimed has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's primary indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
| Begin Period Cash Flow | 3 M | |
| Total Cashflows From Investing Activities | -16.6 M |
Marimed |
Marimed Relative Risk vs. Return Landscape
If you would invest 12.00 in Marimed on November 3, 2025 and sell it today you would lose (3.21) from holding Marimed or give up 26.75% of portfolio value over 90 days. Marimed is currently does not generate positive expected returns and assumes 8.5791% risk (volatility on return distribution) over the 90 days horizon. In different words, 77% of otc stocks are less volatile than Marimed, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Marimed Target Price Odds to finish over Current Price
The tendency of Marimed OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.09 | 90 days | 0.09 | about 68.92 |
Based on a normal probability distribution, the odds of Marimed to move above the current price in 90 days from now is about 68.92 (This Marimed probability density function shows the probability of Marimed OTC Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Marimed has a beta of -0.16. This indicates as returns on the benchmark increase, returns on holding Marimed are expected to decrease at a much lower rate. During a bear market, however, Marimed is likely to outperform the market. Additionally Marimed has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Marimed Price Density |
| Price |
Predictive Modules for Marimed
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Marimed. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Marimed Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Marimed is not an exception. The market had few large corrections towards the Marimed's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Marimed, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Marimed within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.39 | |
β | Beta against Dow Jones | -0.16 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | -0.05 |
Marimed Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Marimed for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Marimed can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Marimed generated a negative expected return over the last 90 days | |
| Marimed has high historical volatility and very poor performance | |
| Marimed has some characteristics of a very speculative penny stock | |
| About 18.0% of the company outstanding shares are owned by corporate insiders |
Marimed Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Marimed OTC Stock often depends not only on the future outlook of the current and potential Marimed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Marimed's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 334 M | |
| Cash And Short Term Investments | 29.9 M |
Marimed Fundamentals Growth
Marimed OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Marimed, and Marimed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Marimed OTC Stock performance.
| Return On Equity | 0.0303 | |||
| Return On Asset | 0.0921 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 178.51 M | |||
| Shares Outstanding | 339.35 M | |||
| Price To Earning | 63.75 X | |||
| Price To Book | 2.96 X | |||
| Price To Sales | 1.04 X | |||
| Revenue | 121.46 M | |||
| EBITDA | 28.96 M | |||
| Cash And Equivalents | 8.44 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 448.34 K | |||
| Debt To Equity | 0.35 % | |||
| Book Value Per Share | 0.16 X | |||
| Cash Flow From Operations | 35.85 M | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 123.2 M | |||
| Retained Earnings | (109.57 M) | |||
| Current Asset | 1.98 M | |||
| Current Liabilities | 3.16 M | |||
About Marimed Performance
By analyzing Marimed's fundamental ratios, stakeholders can gain valuable insights into Marimed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Marimed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Marimed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts. Marimed operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 260 people.Things to note about Marimed performance evaluation
Checking the ongoing alerts about Marimed for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Marimed help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Marimed generated a negative expected return over the last 90 days | |
| Marimed has high historical volatility and very poor performance | |
| Marimed has some characteristics of a very speculative penny stock | |
| About 18.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Marimed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Marimed's stock is overvalued or undervalued compared to its peers.
- Examining Marimed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Marimed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Marimed's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Marimed's otc stock. These opinions can provide insight into Marimed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Marimed OTC Stock analysis
When running Marimed's price analysis, check to measure Marimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marimed is operating at the current time. Most of Marimed's value examination focuses on studying past and present price action to predict the probability of Marimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marimed's price. Additionally, you may evaluate how the addition of Marimed to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stocks Directory Find actively traded stocks across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance |